Matching slides 119,566
Current window 82,261-82,290
Pages 3,986
Rows per page 30
Component: Imageclear collectionreset all

Component

82,261-82,290 of 119,566

filter-aware
07
Roivant Sciences | Investor Presentation Deck | 21 slidesRoivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
11
The slide uses molecular ribbon diagrams to illustrate binding site interference.Roivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
12
Includes financial runway disclosure in the footer.Roivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
18
Roivant Sciences | Investor Presentation Deck | 21 slidesRoivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
19
Roivant Sciences | Investor Presentation Deck | 21 slidesRoivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
01
Slide 1
Includes exhibit number and presenter credentials.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
02
Page number 2 in the top right corner.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
03
SAB Biotherapeutics | Results Presentation Deck | 12 slidesSAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
04
The slide uses a process flow diagram to explain a proprietary biotechnology manufacturing method.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
07
Clinical trial design disclosure.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
11
SAB Biotherapeutics | Results Presentation Deck | 12 slidesSAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
04
Salvatore Ferragamo | Results Presentation Deck | 13 slidesSalvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
Salvatore Ferragamo | Results Presentation Deck | 13 slidesSalvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Signature Bank | Results Presentation Deck | 3 slidesSignature Bank | Results Presentation Deck | 3 slides · Signature Bank
Conference presentation Investor relations Beat · Attention1 hit
02
Skillsoft | Results Presentation Deck | 14 slidesSkillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations 1 hit
09
Skillsoft | Results Presentation Deck | 14 slidesSkillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations 1 hit
01
Slide 1
The slide features a high-quality photograph of an aircraft hangar facility.SkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations 1 hit
02
SkyHarbour | Investor Presentation Deck | 8 slidesSkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations 1 hit
03
SkyHarbour | Investor Presentation Deck | 8 slidesSkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · Problem1 hit
06
SkyHarbour | Investor Presentation Deck | 8 slidesSkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
SkyHarbour | Investor Presentation Deck | 8 slidesSkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · Action1 hit
02
TCR2 Therapeutics | Results Presentation Deck | 34 slidesTCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit
05
The slide uses a visual comparison framework to position TRuC-T cells as a superior technological evolution.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
06
The slide uses a 2x2 layout to present four distinct experimental results supporting the superiority of TRuC technology.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
10
Includes longitudinal CT scan imagery and a line chart tracking tumor diameter and volume reduction.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
12
The slide uses a central human anatomy diagram to map specific cancer types to their respective mesothelin expression rates.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
22
Includes longitudinal CT scan imagery and a line chart tracking tumor diameter and volume reduction over time.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
32
Uses multiparameter immunofluorescence to visualize tumor markers (PanCK), T cells (CD3), TAMs (CD68), and inhibitory ligands (CD155, PD-L1).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
34
The slide features a large stylized '2' from the company logo as a background element.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
01
Slide 1
Third Harmonic Bio | IPO Presentation Deck | 24 slidesThird Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank 1 hit